CD

CNS Drugs

CNS Drugs provides researchers and healthcare professionals with information on drug therapies for the management of neurological and psychiatric disorders. The journal publishes reviews and original research articles addressing pharmacology, efficacy, adverse effects, newly developed drugs and drug classes, therapeutic implications of research into disease aetiology, and practical management of specific clinical situations.

Looking to publish in CNS Drugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Clinical Neurology, Pharmacology & Pharmacy, Psychiatry
Impact Factor 7.4
Quartile Q1
Open Access Type Hybrid
ISSN 1172-7047
eISSN 1179-1934
Invitation Only No
Cost Range £3290.00 GBP / $5290.00 USD / €4190.00 EUR APC for open access; no APC for subscription publishing.

Submission Instructions

CNS Drugs accepts the following article types. Click on an article type to view submission instructions.

Review Article

Cover Letter A cover letter is required and must state the article type, explain the paper's importance and interest to the journal's readership, briefly describe the review's coverage, and include any other pertinent information. The cover letter must identify the article type, outline why the paper is important, briefly describe what is covered in the review, explain why it would interest the journal’s readership, and include any other pertinent information.
Abstract An abstract is required. Abstract must be 150 to 250 words.
Manuscript Manuscript must be up to 8000 words, excluding the abstract, references, figure legends, and table captions. The manuscript must include Key Points beneath the abstract, a Declarations section, documentation of any LLM use in a suitable manuscript section, a statement of author contributions, a statement identifying who conceived the article, performed the literature search and data analysis, and drafted or critically revised the work, and a disclosure statement.
References There is no limit on the number of references. Citations must use numbered references in square brackets. References must be numbered consecutively, include only cited published or accepted works, and include full DOI links when available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text and uploaded separately only if file size causes upload problems. Figures and tables must be numbered with Arabic numerals and cited in consecutive numerical order, each table must have a caption, and each figure must have a concise descriptive caption included in the manuscript text file.
Reformat to CNS Drugs using Livewrite Premium

Systematic Review

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and may be up to 450 words if needed for full compliance with relevant reporting guidelines. Abstract may be increased to up to 450 words if needed for full compliance with relevant reporting guidelines.
Manuscript Systematic Review manuscript must be no more than 10,000 words, excluding the abstract, references, figure legends, and table captions. Manuscript must include a Declarations section, two to three Key Points bullet points beneath the abstract, disclosure statements, and any systematic review registration number in the Methods section and at the end of the abstract if registered.
References There is no limit on the number of references. References must use numbered citations in square brackets. Reference list entries must be numbered consecutively and include only works cited in the text that have been published or accepted for publication.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text and uploaded separately only if file size causes upload problems. Tables and figures must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by captions, with figure captions included in the manuscript text file.
Reformat to CNS Drugs using Livewrite Premium

Original Research

Cover Letter A cover letter is required. Cover letter must state the article type, explain why the paper is important and of interest to the journal’s readership, briefly describe what was found in the study, and include any other pertinent information.
Abstract An abstract is required. Abstract must be 150 to 250 words, but may be increased to 450 words if needed for full compliance with relevant reporting guidelines. Abstract must be structured.
Manuscript Manuscript must be up to 6000 words, excluding the abstract, references, figure legends, and table captions. Original clinical research must list the trial registration number at the end of the abstract. Manuscript must include a Declarations section, two to three non-technical Key Points beneath the abstract, a Data Availability Statement explaining access to supporting data with links or citations to archived datasets, a disclosure statement, and documentation of any LLM use in the Methods section or suitable alternative part of the manuscript.
References There is no limit on the number of references. References must be cited in the text with numbers in square brackets and listed consecutively in numerical order, including only cited works that have been published or accepted for publication.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text and submitted separately only if file size causes upload problems. Figures and tables must be numbered with Arabic numerals, cited in consecutive numerical order in the text, and accompanied by captions, with figure captions included in the manuscript text file.
Reformat to CNS Drugs using Livewrite Premium

Narrative Reviews

Cover Letter A covering letter is required. The covering letter must state the article type, explain why the paper is important and of interest to the journal’s readership, briefly describe the review content, and include any other pertinent information.
Abstract An abstract is required. The abstract must be 150 to 250 words. The abstract must be unstructured with no headings.
Manuscript The manuscript must include a disclosure statement, a Declarations section with relevant statements, two to three Key Points under the heading "Key Points" beneath the abstract, and documentation of any LLM use in a suitable manuscript section.
References There is no limit on the number of references. References must use numbered citations in square brackets. The reference list must contain only cited published or accepted works, be numbered consecutively, and include full DOI links when available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. Figures and tables must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by concise captions.
Reformat to CNS Drugs using Livewrite Premium

Therapy In Practice

Cover Letter A cover letter is required. Cover letter must state the article type, explain why the paper is important and of interest to the journal’s readership, briefly describe the review or study findings, and include any other pertinent information.
Abstract An abstract is required. Abstract must be 150 to 250 words.
Manuscript Manuscript must be no more than 5000 words, excluding the abstract, references, figure legends, and table captions. Manuscript must include a Declarations section, a Competing Interests or Conflicts of Interest statement, two to three Key Points bullets beneath the abstract, and disclosure of any large language model use in the Methods section or another suitable section if no Methods section is available.
References There is no limit on the number of references. Citations must appear as numbers in square brackets in the text, and the reference list must be numbered consecutively and include only cited works that have been published or accepted for publication.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text and submitted separately only if file size causes upload problems. Figures and tables must be numbered with Arabic numerals and cited in consecutive numerical order, with each table and figure accompanied by a caption.
Reformat to CNS Drugs using Livewrite Premium

Letter To The Editor

Cover Letter A cover letter is required. Cover letter must state the article type, explain the paper’s importance and relevance to the journal’s readership, briefly describe the review or findings, include any other pertinent information, and confirm approval by all co-authors.
Abstract An abstract is required. Abstract must be 150 to 250 words.
Manuscript Letter To The Editor must be up to 1000 words, excluding the abstract, references, figure legends, and table captions. Manuscript must include a Declarations or Statements and Declarations section, a Competing Interests or Conflicts of Interest statement, two to three Key Points beneath the abstract, and disclosure of any LLM use in the Methods section or another suitable section if no Methods section is available.
References There is no limit on the number of references. Citations must be numbered in square brackets in the text, and reference list entries must be numbered consecutively and include only cited works that have been published or accepted for publication.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text and submitted separately only if file size causes upload problems. Figures and tables must be numbered with Arabic numerals and cited in consecutive numerical order, with each figure and table accompanied by a descriptive caption.
Reformat to CNS Drugs using Livewrite Premium

Research Letter

Cover Letter A cover letter is required. Cover letter must state the article type, explain the paper's importance and relevance to the journal's readership, briefly describe what the study found, and include any other pertinent information.
Abstract An abstract should be included with the submission. Abstract must be 150 to 250 words.
Manuscript Manuscript must be up to 1500 words, excluding the abstract, references, figure legends, and table captions. Manuscript must include a Key Points section with two to three short bullet points beneath the abstract, a Declarations or Statements and Declarations section before the reference list, and disclosure of any large language model use in the Methods section or another suitable section if no Methods section is available.
References Reference list may include up to 10 references. Citations must be numbered in square brackets in the text, and reference list entries must be numbered consecutively and include only cited published or accepted works.
Figures & Tables Submission may include up to 2 tables or figures in total. Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. Tables and figures must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by captions, with figure captions included in the manuscript text file.
Reformat to CNS Drugs using Livewrite Premium

Recent Publications

Parental Cardiometabolic History, Family Income, and Cardiometabolic Risk in Antipsychotic-Treated Children, Adolescents, and Young Adults: A Nationwide Cohort Study

Mikkel Højlund, Rikke Wesselhoeft, Anne Katrine Pagsberg, Christoph U. Correll, Hans-Christoph Steinhausen

10.1007/s40263-026-01338-0
View Publication

A Phase 3, Multicenter, Randomized, Placebo-Controlled Trial Evaluating the Efficacy, Safety, and Tolerability of Serdexmethylphenidate/d-Methylphenidate Capsules in Chinese Children with Attention-Deficit/Hyperactivity Disorder

Jing Liu, Ying Yang, Yi Wang, Jinjin Chen, Rongwang Yang, Yonghua Cui, Lili Zhang, Wenjing Liu, Fan He, Li Yang, Defeng Xu, Jinhua Sun, Aidina Aisikeer, Xiaoli Fan, Jingran Liu, Lei Wang, Zhengqi Sun, Tan Jia, Jun Qi, Jim Z. Wu, Yi Zheng

10.1007/s40263-026-01341-5
View Publication

Cognitive Effects of Cenobamate as Compared to Perampanel: A Cross-Sectional Multicentre Study in 600 Patients

Juri-Alexander Witt, Judit Catalán-Aguilar, Elisa Schütz, Randi von Wrede, Kevin G. Hampel, Yulia Novitskaya, Rainer Surges, Mercedes Garcés, Birgitta Metternich, Kathrin Wagner, Vicente Villanueva, Christoph Helmstaedter

10.1007/s40263-026-01340-6
View Publication

Eculizumab and Ravulizumab During Pregnancy in Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis: Balancing Maternal Disease Control and Fetal Safety

Eva Dhupia, Jennifer A. McCombe, Sean J. Pittock, Nabeela Nathoo

10.1007/s40263-026-01339-z
View Publication

Rozanolixizumab: A Review in AChR or MuSK Autoantibody-Positive Generalised Myasthenia Gravis

Aisling McGuigan, Hannah A. Blair

10.1007/s40263-026-01335-3
View Publication

Frequently asked questions

How long does it take to publish?

Articles are published online after receipt of the corrected proofs.

Reformat to CNS Drugs using Livewrite Premium

Is a cover letter required?

A covering letter should be included with submission and should state the article type, why the paper is important, what is covered in the review or found in the study, why it would interest the journal readership, and any other pertinent information. If the manuscript was previously reviewed by another journal, prior editorial or referee comments and the response to them should also be provided.

Reformat to CNS Drugs using Livewrite Premium

What are the publication costs?

Open access APC: £3290.00 GBP / $5290.00 USD / €4190.00 EUR, subject to VAT or local taxes where applicable. Subscription publishing has no APC.

Reformat to CNS Drugs using Livewrite Premium

Research Topics

Schizophrenia research and treatment Epilepsy research and treatment Treatment of Major Depression Pharmacological Effects and Toxicity Studies Bipolar Disorder and Treatment Neurotransmitter Receptor Influence on Behavior Neuroscience and Neuropharmacology Research Parkinson's Disease Mechanisms and Treatments Attention Deficit Hyperactivity Disorder Multiple Sclerosis Research Studies Electroconvulsive Therapy Studies Migraine and Headache Studies Neurological disorders and treatments Tryptophan and brain disorders Sleep and Wakefulness Research Sleep and related disorders Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Obsessive-Compulsive Spectrum Disorders Acute Ischemic Stroke Management Cholinesterase and Neurodegenerative Diseases Alzheimer's disease research and treatments Peripheral Neuropathies and Disorders Pain Mechanisms and Treatments Botulinum Toxin and Related Neurological Disorders Parkinson's Disease and Spinal Disorders

Related Journals

DA
Drug and Alcohol Dependence Reports Elsevier BV
JO
Journal of Chemotherapy Taylor & Francis
TA
The Annual Review of Pharmacology and Toxicology ANNUAL REVIEWS
Ps
Psychoneuroendocrinology Elsevier BV
AJ
American Journal of Cardiovascular Drugs Adis, Springer Healthcare
TP
The Pharmacogenomics Journal Springer Nature